Bacterial Cytological Profiling (BCP) as a Rapid and Accurate Antimicrobial Susceptibility Testing Method for Staphylococcus aureus

EBioMedicine

Volumn 4, Issue , 2016, Pages 95-103

  Quach, D T ^a,d   Sakoulas, G ^b   Nizet, V ^b,c   Pogliano, J ^d   Pogliano, K ^d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Antibiotic resistance; Multidrug resistant bacteria; Staphylococcus aureus; Susceptibility tests

Indexed keywords

BETA LACTAM; CEFALEXIN; DAPTOMYCIN; OXACILLIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CELL CULTURE; CYTODIAGNOSIS; GENETIC ANALYSIS; HOUSEKEEPING GENE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; ANTIBIOTIC RESISTANCE; BACTERIUM IDENTIFICATION; CLASSIFICATION; CYTOLOGY; DRUG EFFECTS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PROCEDURES;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; DAPTOMYCIN; DRUG RESISTANCE, BACTERIAL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 84962128048     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.01.020     Document Type: Article

References (55)

1. ADD-Vantage®, Oxacillin Sodium ADD-Vantage® Princeton. 2015, Sandoz Inc., NJ.
2. Aiba, Y., Katayama, Y., Hishinuma, T., Murakami-Kuroda, H., Cui, L., Hiramatsu, K., Mutation of RNA polymerase β-subunit gene promotes heterogeneous-to-homogeneous conversion of β-lactam resistance in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 57 (2013), 4861–4871.
3. Andersson, D.I., Levin, B.R., The biological cost of antibiotic resistance. Curr. Opin. Microbiol. 2 (1999), 489–493.
4. Bauer, K.A., West, J.E., Balada-Llasat, J.M., Pancholi, P., Stevenson, K.B., Goff, D.A., An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia. Clin. Infect. Dis. 51 (2010), 1074–1080.
5. Bayer, A.S., Mishra, N.N., Chen, L., Kreiswirth, B.N., Rubio, A., Yang, S.J., Frequency and distribution of single-nucleotide polymorphisms within mprF in methicillin-resistant Staphylococcus aureus clinical isolates and their role in cross-resistance to daptomycin and host defense antimicrobial peptides. Antimicrob. Agents Chemother. 59 (2015), 4930–4937.
6. Bayer, A.S., Schneider, T., Sahl, H.G., Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall. Ann. N. Y. Acad. Sci. 1277 (2013), 139–158.
7. Berti, A.D., Baines, S.L., Howden, B.P., Sakoulas, G., Nizet, V., Proctor, R.A., Rose, W.E., Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibiotics. Antimicrob. Agents Chemother. 59 (2015), 2799–2806.
8. Best, G.K., Best, N.H., Koval, A.V., Evidence for participation of autolysins in bactericidal action of oxacillin on Staphylococcus aureus. Antimicrob. Agents Chemother. 6 (1974), 825–830.
9. Charles, P.G., Ward, P.B., Johnson, P.D., Howden, B.P., Grayson, M.L., Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus. Clin. Infect. Dis. 38 (2004), 448–451.
10. Choi, J., Jung, Y.G., Kim, J., Kim, S., Jung, Y., Na, H., Kwon, S., Rapid antibiotic susceptibility testing by tracking single cell growth in a microfluidic agarose channel system. Lab Chip 13 (2013), 280–287.
11. Choi, J., Yoo, J., Lee, M., Kim, E.G., Lee, J.S., Lee, S., Joo, S., Song, S.H., Kim, E.C., Lee, J.C., Kim, H.C., Jung, Y.G., Kwon, S., A rapid antimicrobial susceptibility test based on single-cell morphological analysis. Sci. Transl. Med., 6, 2014 (267ra174).
12. CLSI, Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. CLSI document M100-S17, 2007, Clinical and Laboratory Standards Institute, Wayne, PA.
13. CLSI, Method for dilution antimicrobial susceptibility test for bacteria that grow aerobically; approved standard. CLSI document M07-A9, Ninth ed., 2012, Clinical and Laboratory Standards Institute, Wayne, PA.
14. Diaz, L., Tran, T.T., Munita, J.M., Miller, W.R., Rincon, S., Carvajal, L.P., Wollam, A., Reyes, J., Panesso, D., Rojas, N.L., Shamoo, Y., Murray, B.E., Weinstock, G.M., Arias, C.A., Whole-genome analyses of Enterococcus faecium isolates with diverse daptomycin MICs. Antimicrob. Agents Chemother. 58 (2014), 4527–4534.
15. Ender, M., Mccallum, N., Adhikari, R., Berger-Bächi, B., Fitness cost of SCCmec and methicillin resistance levels in Staphylococcus aureus. Antimicrob. Agents Chemother. 48 (2004), 2295–2297.
16. García-Álvarez, L., Holden, M.T., Lindsay, H., Webb, C.R., Brown, D.F., Curran, M.D., Walpole, E., Brooks, K., Pickard, D.J., Teale, C., Parkhill, J., Bentley, S.D., Edwards, G.F., Girvan, E.K., Kearns, A.M., Pichon, B., Hill, R.L., Larsen, A.R., Skov, R.L., Peacock, S.J., Maskell, D.J., Holmes, M.A., Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect. Dis. 11 (2011), 595–603.
17. Goff, D.A., Jankowski, C., Tenover, F.C., Using rapid diagnostic tests to optimize antimicrobial selection in antimicrobial stewardship programs. Pharmacotherapy 32 (2012), 677–687.
18. Gordon, R.J., Lowy, F.D., Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin. Infect. Dis. 46:Suppl. 5 (2008), S350–S359.
19. Gwynn, M.N., Portnoy, A., Rittenhouse, S.F., Payne, D.J., Challenges of antibacterial discovery revisited. Ann. N. Y. Acad. Sci. 1213 (2010), 5–19.
20. Hindler, J.A., Wong-Beringer, A., Charlton, C.L., Miller, S.A., Kelesidis, T., Carvalho, M., Sakoulas, G., Nonejuie, P., Pogliano, J., Nizet, V., Humphries, R., In vitro activity of daptomycin in combination with β-lactams, gentamicin, rifampin, and tigecycline against daptomycin-nonsusceptible enterococci. Antimicrob. Agents Chemother. 59 (2015), 4279–4288.
21. Hososaka, Y., Hanaki, H., Endo, H., Suzuki, Y., Nagasawa, Z., Otsuka, Y., Nakae, T., Sunakawa, K., Characterization of oxacillin-susceptible mecA-positive Staphylococcus aureus: a new type of MRSA. J. Infect. Chemother. 13 (2007), 79–86.
22. Humphries, R.M., Pollett, S., Sakoulas, G., A current perspective on daptomycin for the clinical microbiologist. Clin. Microbiol. Rev. 26 (2013), 759–780.
23. Ito, T., Katayama, Y., Hiramatsu, K., Cloning and nucleotide sequence determination of the entire mec DNA of pre-methicillin-resistant Staphylococcus aureus N315. Antimicrob. Agents Chemother. 43 (1999), 1449–1458.
24. Ji, Y., Methicillin-resistant Staphylococcus aureus (MRSA) protocols. Methods in Molecular Biology, 2007, Humana Press, Totowa, NJ.
25. Kalashnikov, M., Lee, J.C., Campbell, J., Sharon, A., Sauer-Budge, A.F., A microfluidic platform for rapid, stress-induced antibiotic susceptibility testing of Staphylococcus aureus. Lab Chip 12 (2012), 4523–4532.
26. Kamentsky, L., Jones, T.R., Fraser, A., Bray, M.A., Logan, D.J., Madden, K.L., Ljosa, V., Rueden, C., Eliceiri, K.W., Carpenter, A.E., Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis software. Bioinformatics 27 (2011), 1179–1180.
27. Kinnunen, P., Mcnaughton, B.H., Albertson, T., Sinn, I., Mofakham, S., Elbez, R., Newton, D.W., Hunt, A., Kopelman, R., Self-assembled magnetic bead biosensor for measuring bacterial growth and antimicrobial susceptibility testing. Small 8 (2012), 2477–2482.
28. Lamsa, A., Liu, W.T., Dorrestein, P.C., Pogliano, K., The Bacillus subtilis cannibalism toxin SDP collapses the proton motive force and induces autolysis. Mol. Microbiol. 84 (2012), 486–500.
29. Laurent, F., Chardon, H., Haenni, M., Bes, M., Reverdy, M.E., Madec, J.Y., Lagier, E., Vandenesch, F., Tristan, A., MRSA harboring mecA variant gene mecC, France. Emerg. Infect. Dis. 18 (2012), 1465–1467.
30. Levine, D.P., Vancomycin: a history. Clin. Infect. Dis. 42:Suppl. 1 (2006), S5–12.
31. Ligozzi, M., Bernini, C., Bonora, M.G., De Fatima, M., Zuliani, J., Fontana, R., Evaluation of the VITEK 2 system for identification and antimicrobial susceptibility testing of medically relevant gram-positive cocci. J. Clin. Microbiol. 40 (2002), 1681–1686.
32. Lin, L., Nonejuie, P., Munguia, J., Hollands, A., Olson, J., Dam, Q., Kumaraswamy, M., Rivera, H., Corriden, R., Rohde, M., Hensler, M.E., Burkart, M.D., Pogliano, J., Sakoulas, G., Nizet, V., Azithromycin synergizes with cationic antimicrobial peptides to exert bactericidal and therapeutic activity against highly multidrug-resistant gram-negative bacterial pathogens. EBioMedicine 2 (2015), 690–698.
33. Matsuda, K., Nakamura, K., Adachi, Y., Inoue, M., Kawakami, M., Autolysis of methicillin-resistant Staphylococcus aureus is involved in synergism between imipenem and cefotiam. Antimicrob. Agents Chemother. 39 (1995), 2631–2634.
34. Mediavilla, J.R., Chen, L., Mathema, B., Kreiswirth, B.N., Global epidemiology of community-associated methicillin resistant Staphylococcus aureus (CA-MRSA). Curr. Opin. Microbiol. 15 (2012), 588–595.
35. Memmi, G., Filipe, S.R., Pinho, M.G., Fu, Z., Cheung, A., Staphylococcus aureus PBP4 is essential for beta-lactam resistance in community-acquired methicillin-resistant strains. Antimicrob. Agents Chemother. 52 (2008), 3955–3966.
36. Memmi, G., Nair, D.R., Cheung, A., Role of ArlRS in autolysis in methicillin-sensitive and methicillin-resistant Staphylococcus aureus strains. J. Bacteriol. 194 (2012), 759–767.
37. Mishra, N.N., Bayer, A.S., Weidenmaier, C., Grau, T., Wanner, S., Stefani, S., Cafiso, V., Bertuccio, T., Yeaman, M.R., Nast, C.C., Yang, S.J., Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons. PLoS One, 9, 2014, e107426.
38. Moore, C.L., Osaki-Kiyan, P., Haque, N.Z., Perri, M.B., Donabedian, S., Zervos, M.J., Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study. Clin. Infect. Dis. 54 (2012), 51–58.
39. Murray, K.P., Zhao, J.J., Davis, S.L., Kullar, R., Kaye, K.S., Lephart, P., Rybak, M.J., Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration > 1 mg/L: a matched cohort study. Clin. Infect. Dis. 56 (2013), 1562–1569.
40. Nimmo, G.R., USA300 abroad: global spread of a virulent strain of community-associated methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 18 (2012), 725–734.
41. Nonejuie, P., Burkart, M., Pogliano, K., Pogliano, J., Bacterial cytological profiling rapidly identifies the cellular pathways targeted by antibacterial molecules. Proc. Natl. Acad. Sci. 110 (2013), 16169–16174.
42. NOVATION, Meropenem. 2014, Irving, Tx.
43. PFIZER, Cefotaxime. 2009, NY, New York.
44. Pinho, M.G., Filipe, S.R., De Lencastre, H., Tomasz, A., Complementation of the essential peptidoglycan transpeptidase function of penicillin-binding protein 2 (PBP2) by the drug resistance protein PBP2A in Staphylococcus aureus. J. Bacteriol. 183 (2001), 6525–6531.
45. Price, C.S., Kon, S.E., Metzger, S., Rapid antibiotic susceptibility phenotypic characterization of Staphylococcus aureus using automated microscopy of small numbers of cells. J. Microbiol. Methods 98 (2014), 50–58.
46. Rice, L.B., Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J. Infect. Dis. 197 (2008), 1079–1081.
47. Sakoulas, G., Kumaraswamy, M., Nonejuie, P., Werth, B., Rybak, M.J., Pogliano, J., Rice, L.B., Nizet, V., Differential effects of penicillin binding protein deletion on the susceptibility of Enterococcus faecium to cationic peptide antibiotics. Antimicrob. Agents Chemother, 2015.
48. Sakoulas, G., Nonejuie, P., Kullar, R., Pogliano, J., Rybak, M.J., Nizet, V., Examining the use of ceftaroline in the treatment of Streptococcus pneumoniae meningitis with reference to human cathelicidin LL-37. Antimicrob. Agents Chemother. 59 (2015), 2428–2431.
49. Sinn, I., Albertson, T., Kinnunen, P., Breslauer, D.N., Mcnaughton, B.H., Burns, M.A., Kopelman, R., Asynchronous magnetic bead rotation microviscometer for rapid, sensitive, and label-free studies of bacterial growth and drug sensitivity. Anal. Chem. 84 (2012), 5250–5256.
50. Stevens, D.L., The role of vancomycin in the treatment paradigm. Clin. Infect. Dis. 42:Suppl. 1 (2006), S51–S57.
51. Takano, T., Hung, W.C., Shibuya, M., Higuchi, W., Iwao, Y., Nishiyama, A., Reva, I., Khokhlova, O.E., Yabe, S., Ozaki, K., Takano, M., Yamamoto, T., A new local variant (ST764) of the globally disseminated ST5 lineage of hospital-associated methicillin-resistant Staphylococcus aureus (MRSA) carrying the virulence determinants of community-associated MRSA. Antimicrob. Agents Chemother. 57 (2013), 1589–1595.
52. Tong, S.Y., Davis, J.S., Eichenberger, E., Holland, T.L., Fowler, V.G., Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin. Microbiol. Rev. 28 (2015), 603–661.
53. Werth, B.J., Steed, M.E., Ireland, C.E., Tran, T.T., Nonejuie, P., Murray, B.E., Rose, W.E., Sakoulas, G., Pogliano, J., Arias, C.A., Rybak, M.J., Defining daptomycin resistance prevention exposures in vancomycin-resistant Enterococcus faecium and E. faecalis. Antimicrob. Agents Chemother. 58 (2014), 5253–5261.
54. Wertheim, H.F., Melles, D.C., Vos, M.C., Van Leeuwen, W., Van Belkum, A., Verbrugh, H.A., Nouwen, J.L., The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 5 (2005), 751–762.
55. Wilson, D.N., Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nat. Rev. Microbiol. 12 (2014), 35–48.